AKT1 and hepatocellular carcinoma: Gaining a comprehensive understanding of these mechanisms, particularly the intricate involvement of the PI3K/Akt/mTOR pathway, is crucial for the development of effective prevention and treatment strategies targeting HBV‐related HCC.